Doxercalciferol
Back to searchMolecule Structure
Scientific Name
Doxercalciferol
Description of the Drug
Doxercalciferol is a synthetic vitamin D2 analog used to treat secondary hyperparathyroidism in patients with chronic kidney disease with or without therapy of dialysis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06410
http://www.drugbank.ca/drugs/DB06410
Brand Name(s)
Doxercalciferol, Hectorol
Company Owner(s)
Sandoz Inc, Avet Pharmaceuticals Inc, Hospira Inc, Sun Pharmaceutical Industries Ltd, Hikma Pharmaceuticals Llc, Gland Pharma Ltd, Eugia Pharma Specialities Ltd, Meitheal Pharmaceuticals Inc, Amneal Eu Ltd, Sanofi Genzyme
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Vitamin D receptor | SINGLE PROTEIN | AGONIST | CHEMBL1977 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL322422 | |
| DrugBank | DB06410 | |
| PubChem: Thomson Pharma | 14831187 | 14757783 |
| PubChem | 5281107 | |
| PDBe | V2H | |
| EPA CompTox Dashboard | DTXSID1034214 | |
| LipidMaps | LMST03010028 | |
| DrugCentral | 957 | |
| Brenda | 12174 | 168070 |
| Rhea | 4712 | |
| ChemicalBook | CB8394169 | |
| Guide to Pharmacology | 2790 | |
| SwissLipids | SLM:000485672 | |
| rxnorm | DOXERCALCIFEROL | HECTOROL |
| KEGG Ligand | C08211 | |
| ChEBI | 4712 | |
| ZINC | ZINC000004641374 |
